Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value and an activist investor is agitating for change.
Source link : https://www.washingtonpost.com/business/2024/10/14/pfizer-bourla-covid-vaccine-investors/
Author : Daniel Gilbert
Publish date : 2024-10-14 10:00:40
Copyright for syndicated content belongs to the linked Source.
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
